Precision therapeutics
The Right Drugs for the Right Patients at the Right Time
Developing More Cures for More Patients
Human Insight Based
Discover and develop new cancer therapies directed at targets driving resistance to the current standard of care
Biomarker Selected
Develop blood-based biomarkers for easy and rapid identification of patients that will benefit from each specific new cancer therapy
Precision Development
Combine blood-based biomarkers with dynamic precision clinical trial design to develop more effective drugs for more patients faster
Risk Diversification
Incubate therapeutic programs for NewCo creation or biopharma partnership prior to clinical development
A pipeline of precision cancer therapies for patients who do not respond to the existing standard of care.
Developing More Cures for More Patients
Human Insight Based
Discover and develop new cancer therapies directed at targets driving resistance to the current standard of care
Biomarker Selected
Develop blood-based biomarkers for easy and rapid identification of patients that will benefit from each specific new cancer therapy
Precision Development
Combine blood-based biomarkers with dynamic precision clinical trial design to develop more effective drugs for more patients faster
Risk Diversification
Incubate therapeutic programs for NewCo creation or biopharma partnership prior to clinical development
A pipeline of precision cancer therapies for patients who do not respond to the existing standard of care.
